Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Park-IMPULSE: Serotoninergic System in PD Impulse Control Disorders
NCT03970239Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2019
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Difference in binding potential of [18 Fluorine]-altanserin and [11 Carbon]-DASB. Status: unknown.
Beyond the preview
Go deeper on NCT03970239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970239.